Smith Anglin Financial, LLC Amneal Pharmaceuticals, Inc. Transaction History
Smith Anglin Financial, LLC
- $982 Million
- Q2 2024
A detailed history of Smith Anglin Financial, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Smith Anglin Financial, LLC holds 29,000 shares of AMRX stock, worth $241,280. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,000
Previous 29,000
-0.0%
Holding current value
$241,280
Previous $175,000
5.14%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$182 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$116 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.2 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.26B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...